Long-term follow up of patients with human immunodeficiency virus infection and advanced stage Hodgkin's lymphoma treated with doxorubicin, bleomycin, vinblastine and dacarbazine

被引：7
|
作者：
Xicoy, Blanca [1 ]
Miralles, Pilar [2 ]
Morgades, Mireia [1 ]
Rubio, Rafael [3 ]
Valencia, Maria-Eulalia [4 ]
Ribera, Josep-Maria [1 ]
机构：
[1] Univ Autonoma Barcelona, ICO Hosp Germans Trias Pujol, Jose Carreras Leukemia Res Inst, Dept Clin Hematol, Badalona, Spain
[2] Hosp Gregorio Maranon, Dept Infect Dis, Madrid, Spain
[3] Hosp 12 Octubre, Dept Infect Dis, E-28041 Madrid, Spain
[4] Hosp Carlos III, Dept Infect Dis, Madrid, Spain
来源：
HAEMATOLOGICA | 2013年 / 98卷 / 08期
关键词：
Hodgkin's lymphoma; HIV-related; long-term follow up; opportunistic infections; second cancers; ACTIVE ANTIRETROVIRAL THERAPY; IMPACT; REGIMEN; HAART;
D O I：
10.3324/haematol.2012.079921
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E85 / E86
页数：2
相关论文
共 50 条
  • [41] LONG-TERM FOLLOW-UP OF DIDANOSINE ADMINISTERED ORALLY TWICE DAILY TO PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND HEMATOLOGIC INTOLERANCE OF ZIDOVUDINE
    ALLAN, JD
    CONNOLLY, KJ
    FITCH, H
    JACKSONPOPE, L
    MCLAREN, C
    CANETTA, R
    GROOPMAN, JE
    CLINICAL INFECTIOUS DISEASES, 1993, 16 : S46 - S51
  • [42] Doxorubicin, Vinblastine and Dacarbazine with or without Bleomycin for Older Patients with Early Stage Favorable Hodgkin Lymphoma: An Analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 Trials
    Boell, Boris
    Behringer, Karolin
    Goergen, Helen
    Broeckelmann, Paul
    von Tresckow, Bastian
    Eichenauer, Dennis A.
    Fuchs, Michael
    Diehl, Volker
    Engert, Andreas
    Borchmann, Peter
    BLOOD, 2014, 124 (21)
  • [43] INCREASED RISK OF COLORECTAL CANCER IN PATIENTS TREATED FOR HODGKIN LYMPHOMA: A LONG-TERM FOLLOW-UP STUDY IN THE NETHERLANDS
    Eggermond, A. V.
    Schaapveld, M.
    Bruin, M. D.
    Ouwens, G.
    Janus, C.
    Krol, S.
    Zijlstra, J.
    Louwman, M.
    Aleman, B.
    Leeuwen, F. V.
    ANNALS OF ONCOLOGY, 2011, 22 : 182 - 182
  • [44] INCREASED RISK OF COLORECTAL CANCER IN PATIENTS TREATED FOR HODGKIN LYMPHOMA: A LONG-TERM FOLLOW-UP STUDY IN THE NETHERLANDS
    van Eggermond, A. M.
    Schaapveld, M.
    de Bruin, M. L.
    Ouwens, G.
    Janus, C.
    Krol, S.
    Louwman, M.
    Aleman, B. M. P.
    van Leeuwen, F. E.
    HAEMATOLOGICA, 2010, 95 : S37 - S37
  • [45] DEVELOPMENT OF NON-HODGKIN LYMPHOMA IN A COHORT OF PATIENTS WITH SEVERE HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION ON LONG-TERM ANTIRETROVIRAL THERAPY
    PLUDA, JM
    YARCHOAN, R
    JAFFE, ES
    FEUERSTEIN, IM
    SOLOMON, D
    STEINBERG, SM
    WYVILL, KM
    RAUBITSCHEK, A
    KATZ, D
    BRODER, S
    ANNALS OF INTERNAL MEDICINE, 1990, 113 (04) : 276 - 282
  • [46] LONG TERM FOLLOW-UP OF ADVANCED HODGKIN LYMPHOMA TREATED WITH BEACOPP REGIMEN - A SINGLE INSTITUTION EXPERIENCE
    Mihaljevic, B.
    Antic, D.
    Jakovic, L. R.
    Andjelic, B.
    Tomin, D.
    Petrovic, M.
    HAEMATOLOGICA, 2010, 95 : S22 - S23
  • [47] Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial
    Luminari, Stefano
    Fossa, Alexander
    Trotman, Judith
    Molin, Daniel
    d'Amore, Francesco
    Enblad, Gunilla
    Berkahn, Leanne
    Barrington, Sally F.
    Radford, John
    Federico, Massimo
    Kirkwood, Amy A.
    Johnson, Peter W. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (01) : 13 - +
  • [48] Granulocyte colony-stimulating factor as secondary prophylaxis of febrile neutropenia in the management of advanced-stage Hodgkin lymphoma treated with adriamycin, bleomycin, vinblastine and dacarbazine chemotherapy: a decision analysis
    Graczyk, Joanna
    Cheung, Matthew C.
    Buckstein, Rena
    Chan, Kelvin
    LEUKEMIA & LYMPHOMA, 2014, 55 (01) : 56 - 62
  • [49] Subsite Specific Risk of Colorectal Cancer Risk in Patients Treated for Hodgkin's Lymphoma: A Long-Term Follow-up Study in the Netherlands
    van Eggermond, Anna M.
    Schaapveld, Michael
    Janus, Cecile P.
    de Boer, Jan Paul
    Krol, Augustinus
    Zijlstra, Josee M.
    Raemaekers, John
    Kremer, Leontien C.
    Louwman, Marieke W.
    Visser, Otto
    De Bruin, Marie L.
    Aleman, Berthe M.
    van Leeuwen, Flora E.
    van Leerdam, Monique E.
    GASTROENTEROLOGY, 2013, 144 (05) : S39 - S39
  • [50] ECHELON-1: three-year follow-up of the combination of brentuximab, vedotin and doxorubicin, vinblastine and dacarbazine as a first-line treatment for advanced stages of classical Hodgkin's lymphoma
    Chiche, Edmond
    Richez-Olivier, Valentine
    HEMATOLOGIE, 2020, 26 (02): : 97 - 98
12345